Schistosomiasis: The Business Case for New Diagnostics

In this document, PATH seeks to synthesize primary scientific literature, technology landscape analyses, and drug development principles to describe key considerations related to the diagnosis and control of schistosomiasis and outline a business case for financing, developing, and deploying new diagnostics for detection of Schistosoma infection.

Publication date: January 2016

Schistosomiasis: The Business Case for New Diagnostics

2 MB PDF

Hard copies are not available.

View Resource